A carregar...
Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial
[Figure: see text] OBJECTIVES: Patients with Kawasaki disease can develop life-altering coronary arterial abnormalities, particularly in those resistant to intravenous immunoglobulin (IVIg) therapy. We tested the tumor necrosis factor α receptor antagonist etanercept for reducing both IVIg resistanc...
Na minha lista:
| Publicado no: | Pediatrics |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Academy of Pediatrics
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6564061/ https://ncbi.nlm.nih.gov/pubmed/31048415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2018-3675 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|